• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
 
FDA
  
FDA Core Presentation, Brilinta (Ticagrelor), for the July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (PDF – 1.1MB)
 
 
AstraZeneca
 
AstraZeneca Core Presentation, Brilinta (Ticagrelo), for the July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (PDF – 5.25MB)
 
AstraZeneca Backup Presentation, Brilinta (Ticagrelor), for the July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (PDF – 1.48MB)